You're reading the free version. Trader adds the live tape and alerts.
Start tracking
JANX Exercise Disclosure
Campbell David Alan · SEC Form 4 · Filed Jul 10, 2026
Exercise
Calculated transaction value
$0
Campbell David Alan President And CEO
JANX
Janux Therapeutics
JANX
Transaction date
Jul 8, 2026
Public filing date
Jul 10, 2026
Filing lag
Filed 2 days later
JANX daily price context
Close on/before transaction
$16.66
Jul 8, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 7,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001864158-26-000004
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$29.47K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Janux Therapeutics, Inc. JANX | Exercise | Jul 8, 2026 | $29.47K |
| Janux Therapeutics, Inc. JANX Current | Exercise | Jul 8, 2026 | $0 |